| Name | Neopanaxadiol |
|---|
| Description | Neopanaxadiol, an aglycone of protopanaxadiol type ginsenosides, has the potential for Alzheimer's disease research[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Neopanaxadiol (30 mg/kg; oral) has a T1/2 of 2.52 hours, a CL of 5.44 L/h•kg, a Cmax of 913.44 ng/mL in dogs[1]. |
| References |
| Molecular Formula | C30H52O3 |
|---|---|
| Molecular Weight | 460.73 |